(Total Views: 479)
Posted On: 04/05/2020 9:58:19 PM
Post# of 153903
Re: Coocooburra #25708
So, how does this play out?
Each of their trials likely end in a predictable order.
Does the FDA approve Gilead's remdesivir?
Or wait to approve Regeneron's Kevzara?
Or wait to approve CytoDyn's leronlimab?
Or does the FDA approve all three drugs, in succession, and monitor the efficacy of all three in the real world?
Furthermore, does the FDA withdraw (or deprecate) approvals for a first and/or second drug (whose clinical finished first) -- when the results of the 3rd drug's clinical show significantly better efficacy?
Each of their trials likely end in a predictable order.
Does the FDA approve Gilead's remdesivir?
Or wait to approve Regeneron's Kevzara?
Or wait to approve CytoDyn's leronlimab?
Or does the FDA approve all three drugs, in succession, and monitor the efficacy of all three in the real world?
Furthermore, does the FDA withdraw (or deprecate) approvals for a first and/or second drug (whose clinical finished first) -- when the results of the 3rd drug's clinical show significantly better efficacy?
(0)
(0)
